Middle East and Africa Sleep Apnea Diagnostics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product (Polysomnography (PSG) Device, Home Sleep Testing Devices, Oximeter, Actigraphy Monitoring Device, and Sleep Apnea Screening Device) and End User (Hospitals and Sleep Laboratories and Home Care Settings)


No. of Pages: 113    |    Report Code: TIPRE00026637    |    Category: Life Sciences

Middle East and Africa Sleep Apnea Diagnostics Market
Buy Now

The sleep apnea diagnostics market in Middle East & Africa is expected to grow from US$ 20.88 million in 2021 to US$ 27.01 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2021 to 2028.

Advancements in knowledge in biology and engineering have equally enhanced the various medical devices such as polysomnography (PSG) device, home sleep testing devices, and others. Many industry players have come up with innovative types of sleep apnea diagnostic devices in the last few years. For instance, in July 2019, CleveMed, a leading home sleep apnea testing company, announces the launch of a new comprehensive sleep care service designed for patients with sleep disorders in the private pay market. Furthermore, in September 2019, Koninklijke Philips N.V. launched Philips NightBalance, a prescription sleep position therapy device designed for patients with positional OSA. The product is likely a non-inferior treatment to continuous positive airway pressure (CPAP) and demonstrate high adherence rates among positional OSA patients. With such advancements, the market is registering tremendous growth.

 

The coronavirus has had a significant impact in the Middle East & Africa. Iran was one of the pandemic's first victims, with fatal cases reported as early as March 2020. Middle East & Africa countries, saw three waves of the pandemic, with a few outliers. However, due to insufficient diagnosis and reporting systems in some countries, a comparable cross-country examination of infection intensity is challenging. The relative frequency of testing can be used as an indirect indicator of the diagnostic system's performance. The United Arab Emirates (UAE) and Bahrain have been regional leaders in terms of testing, outperforming some advanced economies. Obstructive sleep apnea and other sleep disorders have comorbidities with severe acute respiratory syndrome coronavirus 2 infection, which are linked to poor outcomes. However, the prevalence of obstructive sleep apnea and its association with outcomes in COVID-19 patients is little understood, and the significance of other sleep disorders is uncertain. There appears to be a clear link between being overweight or obese and the probability of hospitalization and necessitating treatment in intensive care units for people with coronavirus illness 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ICUs). According to new research, obese people under the age of 60 are more likely to be hospitalized. Obesity prevalence rates are among the highest in the world in the Middle East. Given the exponential rise in the incidence of obesity, knowing how obesity increases the risk of severe COVID-19 infection is crucial for developing effective interventional and preventative treatments for this novel coronavirus.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa sleep apnea diagnostics market. The Middle East & Africa sleep apnea diagnostics market is expected to grow at a good CAGR during the forecast period.

 

 Middle East & Africa Sleep Apnea Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

 Middle East & Africa Sleep Apnea Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report

Middle East and Africa Sleep Apnea Diagnostics Strategic Insights

Strategic insights for the Middle East and Africa Sleep Apnea Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-sleep-apnea-diagnostics-market-strategic-framework.webp
Get more information on this report

Middle East and Africa Sleep Apnea Diagnostics Report Scope

Report Attribute Details
Market size in 2021 US$ 20.88 Million
Market Size by 2028 US$ 27.01 Million
Global CAGR (2021 - 2028) 3.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Polysomnography Device
  • Home Sleep Testing Devices
  • Oximeter
  • Actigraphy Monitoring Device
  • Sleep Apnea Screening Device
By End User
  • Hospitals and Sleep Laboratories and Home Care Settings
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • ResMed Inc.
  • Nihon Kohden Corporation LLC
  • SOMNOmedics GmbH
  • Cleveland Medical Devices Inc.
  • Koninklijke Philips N.V.
  • Natus Medical Incorporated
  • Itamar Medical Ltd.
  • Compumedics Limited
  • Get more information on this report

    Middle East and Africa Sleep Apnea Diagnostics Regional Insights

    The geographic scope of the Middle East and Africa Sleep Apnea Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/middle-east-and-africa-sleep-apnea-diagnostics-market-geography.webp
    Get more information on this report

     

     

    Middle East & Africa Sleep Apnea Diagnostics Market Segmentation

     

    Middle East & Africa Sleep Apnea Diagnostics Market – By Product

    • Polysomnography (PSG) Device
    • Home Sleep Testing Devices
    • Oximeter
    • FingerTip Oximeter
    • Handheld Oximeter
    • Wrist-worn Oximeter
    • Tabletop Oximeter
    • Actigraphy Monitoring Device
    • Sleep Apnea Screening Device

    Middle East & Africa Sleep Apnea Diagnostics Market – By

    End User

    • Hospitals and Sleep Laboratories
    • Home Care Settings

    Middle East & Africa Sleep Apnea Diagnostics Market – By

    Country

    • South Africa
    • Saudi Arabia  
    • UAE
    • Rest of MEA

    Middle East & Africa Sleep Apnea Diagnostics Market – Companies Mentioned

    • ResMed Inc.
    • Nihon Kohden Corporation LLC
    • SOMNOmedics GmbH
    • Cleveland Medical Devices Inc.   
    • Koninklijke Philips N.V.
    • Natus Medical Incorporated
    • Itamar Medical Ltd.
    • Compumedics Limited

    The List of Companies - Middle East and Africa Sleep Apnea Diagnostics Market

    1. ResMed Inc.
    2. Nihon Kohden Corporation LLC
    3. SOMNOmedics GmbH
    4. Cleveland Medical Devices Inc. 
    5. Koninklijke Philips N.V.
    6. Natus Medical Incorporated
    7. Itamar Medical Ltd.
    8. Compumedics Limited
    Frequently Asked Questions
    How big is the Middle East and Africa Sleep Apnea Diagnostics Market?

    The Middle East and Africa Sleep Apnea Diagnostics Market is valued at US$ 20.88 Million in 2021, it is projected to reach US$ 27.01 Million by 2028.

    What is the CAGR for Middle East and Africa Sleep Apnea Diagnostics Market by (2021 - 2028)?

    As per our report Middle East and Africa Sleep Apnea Diagnostics Market, the market size is valued at US$ 20.88 Million in 2021, projecting it to reach US$ 27.01 Million by 2028. This translates to a CAGR of approximately 3.7% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Sleep Apnea Diagnostics Market report typically cover these key segments-

    • Product (Polysomnography Device, Home Sleep Testing Devices, Oximeter, Actigraphy Monitoring Device, Sleep Apnea Screening Device)
    • End User (Hospitals and Sleep Laboratories and Home Care Settings)

    What is the historic period, base year, and forecast period taken for Middle East and Africa Sleep Apnea Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Sleep Apnea Diagnostics Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Middle East and Africa Sleep Apnea Diagnostics Market?

    The Middle East and Africa Sleep Apnea Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ResMed Inc.
  • Nihon Kohden Corporation LLC
  • SOMNOmedics GmbH
  • Cleveland Medical Devices Inc.
  • Koninklijke Philips N.V.
  • Natus Medical Incorporated
  • Itamar Medical Ltd.
  • Compumedics Limited
  • Who should buy this report?

    The Middle East and Africa Sleep Apnea Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Sleep Apnea Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now